Press release
Psoriasis Therapeutics Market Report Explored in Latest Research
Get Sample Copy of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/825
Americas region led the global Psoriasis Therapeutics market, which is attributable to the growing prevalence of the psoriasis in the U.S. and Canada and presence of large companies operating in this market in the region. Moreover, high level of awareness among the people about the use of Psoriasis Therapeutics in the U.S. is a primary driver promoting the growth in this region. Asia-Pacific region is expected to grow at the highest rate over the next six years owing to rapid lifestyle changes among the consumers in India, and China. Moreover, growing healthcare expenditure among the population in the Asia Pacific region is likely to act a major driver in the region.
Biologics dominate the global market for psoriasis diagnostics
According to the report the global market for psoriasis diagnostics is dominated by biologics as a choice for treatment. Enbrel, Humira, and Remicade are among the approved biologic drugs presently used in the treatment of psoriasis. Moreover, several biologic drugs in the pipeline are likely to escalate the demand for biologics for the purpose of treatment of psoriasis over the forecast period. In addition, the raising awareness about psoriasis among the patients is likely to augment the market size psoriasis diagnostics in the years to come.
Make an Enquiry: https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/825
The report segments the global Psoriasis Therapeutics market as:
Global Psoriasis Therapeutics Market by Molecule 2017 - 2023
Biologics
Small Molecules
Global Psoriasis Therapeutics Market by Route of Administration 2017 - 2023
Oral
Parenteral
Topical
Global Psoriasis Therapeutics Market by Dosage forms 2017 - 2023
Solid
Liquid
Semi-solid
Global Psoriasis Therapeutics Market by Mechanism of Action 2017 - 2023
TNF Inhibitors
PDE4 Inhibitors
IL blocker
Others
Companies profiled in the report
Amgen, Inc.
Johnson & Johnson
Eli Lilly and Company
AstraZeneca
Novartis AG
AbbVie Inc.
Celgene Corporation
Other companies in this market
About Us
Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.
Contact Us
Infinium Global Research,
Toll Free:
U.S. + Canada: 1-800-638-0796,
UK: +44-2033182010
Website : https://www.infiniumglobalresearch.com
Email: sales@infiniumglobalresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Therapeutics Market Report Explored in Latest Research here
News-ID: 926396 • Views: …
More Releases from Infinium Global Research
Global High-End Inertial Sensing Market to Reach USD 10.46 Billion by 2032, Grow …
The global high-end inertial sensing market is experiencing substantial growth as industries increasingly demand precision, reliability, and automation. According to Infinium Global Research, the market was valued at USD 6.35 billion in 2023 and is expected to reach USD 10.46 billion by 2032, registering a CAGR of 5.80% during 2024-2032. High-end inertial sensing systems integrate advanced sensors such as gyroscopes, accelerometers, magnetometers, and inertial measurement units to provide precise navigation…
Global CMOS Image Sensor Market to Reach USD 55 Billion by 2032, Driven by a 7% …
The global CMOS image sensor market has established itself as a critical segment within the imaging technology industry. Valued at USD 30.43 billion in 2023, the market is projected to reach USD 55.00 billion by 2032, expanding at a CAGR of 7.00% during the forecast period. CMOS (Complementary Metal-Oxide-Semiconductor) image sensors are essential components that convert light into electrical signals for image processing, powering a wide array of applications from…
Magnetic Sensors Market Forecast 2024-2032: CAGR of 6.4% Signals Strong Growth A …
The global magnetic sensors market has become a cornerstone in modern electronics, automotive, and industrial applications. According to Infinium Global Research, the market was valued at USD 3.43 billion in 2023 and is projected to reach USD 5.94 billion by 2032, reflecting a CAGR of 6.40% during the forecast period. Magnetic sensors detect and measure magnetic fields, converting the information into electrical signals for accurate measurement of strength, direction, and…
RF Front End Module Market to Reach USD 21.93 Billion by 2032, Driven by Growing …
The global RF Front End Module Market has become a cornerstone of the modern communications ecosystem, playing an essential role in mobile devices, wireless infrastructure, and connected technologies. According to a recent report by Infinium Global Research (IGR), the market was valued at USD 13.43 billion in 2023 and is projected to reach USD 21.93 billion by 2032, growing at a CAGR of 5.70% during 2024-2032. The RF front end…
More Releases for Psoriasis
Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual…
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
